Sera Prognostics Announces Completion of Important Prevent PTB Clinical Intervention Study Using the PreTRM® Test
SALT LAKE CITY--(BUSINESS WIRE)--Sera Prognostics, Inc., the leading health diagnostics company dedicated to improve the lives of women and babies through individualized prenatal care, today, announced that the Prevent PTB clinical study conducted by Intermountain Healthcare is being prepared for publication in a peer-reviewed scientific journal. This study is the first of its kind to measure the impact on maternal and neonatal health and healthcare costs when standard medical interventions are ...
